Human pathology

Home page > E. Pathology by systems > Digestive system > Esophagus > esophageal adenocarcinoma

esophageal adenocarcinoma

oesophageal adenocarcinoma

Oesophageal and gastro-oesophgeal junction (GOJ) adenocarcinoma is increasing in incidence and has a poor outcome.

Comparative genomic hybridization (16479570)

- losses

  • Chr.3 loss
  • 4p loss
  • 4q loss
  • 5q loss
  • Chr.6 loss
  • 8p loss
  • 9p loss
  • 17p loss
  • 18q loss
  • Chr.20 loss

- gains

Early adenocarcinoma of the esophagus (T1 stage)

Early (T1 stage) adenocarcinoma of the esophagus or gastroesophageal junction is a potentially curable disease.

See also

- esophageal carcinomas

References

- van Dekken H, Wink JC, Vissers KJ, van Marion R, Koppert LB, Tilanus HW, Siersema PD, Tanke HJ, Szuhai K, Hop WC. Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences. Genes Chromosomes Cancer. 2006 May;45(5):516-25. PMID: 16479570

- Lin L, Wang Z, Prescott MS, van Dekken H, Thomas DG, Giordano TJ, Chang AC, Orringer MB, Gruber SB, Moran JV, Glover TW, Beer DG. Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer. 2006 Apr;45(4):319-31. PMID: 16320248